Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-48521
Samaras, P; Blickenstorfer, M; Haile, S R; Siciliano, D; Petrausch, U; Mischo, A; Zweifel, M; Honegger, H; Schanz, U; Stüssi, G; Taverna, C; Bauer, S; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Medical Weekly, 141:w13203.
View at publisher
ASCT is a safe and effective treatment mode in eligible patients with MM. TRM was below average at our institution. Achievement of CR after transplantation was the most valuable predictor for improved overall survival.
114 downloads since deposited on 28 Jun 2011
32 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Hematology
04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
|Dewey Decimal Classification:||610 Medicine & health|
|Deposited On:||28 Jun 2011 08:56|
|Last Modified:||02 Jun 2015 07:22|
|Publisher:||EMH Swiss Medical Publishers|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page